WEBINAR
Every Day Counts: Raising the Bar in Gene Therapy with Science & Structure
Now available on-demand | recorded live on Dec. 1, 2025
SUMMARY
Every Day Counts: Raising the Bar in Gene Therapy with Science & Structure
How did Viralgen cut their client onboarding timeline from 12 months to 3? Watch Cell & Gene’s on-demand webinar below to find out.
Our very own Joschka Buyel sits down with Ane Quesada, Senior Scientist, MSAT at Viralgen, to talk about how they partnered to get a first-in-class gene therapy manufacturing-ready on a dramatically compressed timeline.
Learn Viralgen's approach to:
Utilizing QbDVision’s Digital CMC platform to standardize documentation, templates, and reports
Structuring their data to improve cross-functional alignment, transparency, and partner confidence
Creating a partnership that can serve as a scalable model for future tech transfers
SPEAKER BIOS
Meet the speakers
Ane Quesada, PhD
Ane Quesada Ganuza is a Senior Scientist in the MSAT (Manufacturing Science and Technology) department at Viralgen, where she specializes in the development and optimization of manufacturing processes for gene therapy products. Her work focuses on adeno-associated virus (AAV) production using advanced platform strategies that enhance consistency, scalability, and regulatory compliance across serotypes and drug products.